GLP-1 receptor agonists, are we witnessing the emergence of a paradigm shift for neuro-cardio-metabolic disorders?.Pharmacol Ther
How do we help our patients
You dont stop your blood pressure medication once you reach your goal, and the same applies here
doi: 10.1016/j.physbeh.2019.03.026 33 BucciarelliLCiminoVDellOssoBFiorinaP
Efficient methylation of catechol estrogens is, therefore, of foremost importance: during methylation, a methyl group is donated by S-adenosylmethionine (SAM) via COMT to ensure that catechol estrogens are converted to methoxyestrogens, thereby limiting the formation of genotoxic estrogen quinones 18
"This is a perfect example on how obesity and weight gain are not lifestyle issues nor lack of willpower," says Rocio Salas-Whalen, MD, is a board-certified endocrinologist specializing in obesity medicine and author of Weightless: A Doctor's Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve